T1	Participants 96 125	nodular basal cell carcinoma.
T2	Participants 210 245	nodular basal cell carcinoma (BCC).
T3	Participants 700 726	patients with nodular BCC.
T4	Participants 735 750	Twenty patients
T5	Participants 1011 1026	Twenty patients
T6	Participants 1050 1068	imiquimod (n = 10)
T7	Participants 1072 1088	vehicle (n = 10)
